Dr. Reddy's debuts Tecfidera generic
Dr. Reddy’s is releasing a new generic.
The company's newest offering is dimethyl fumarate delayed-release capsules, a generic of Biogen’s Tecfidera.
The Tecfidera brand and generic had a market value of approximately $3.8 billion for the most recent 12 months ended June 2020, according to IQVIA.
Dr. Reddy’s generic Tecfidera is available in 120-mg and 240-mg capsules in bottle count sizes of 14 and 60 capsules, respectively.